Use of Orlistat 60 mg in the Management of Weight Loss Before Bariatric Surgery

In the study to evaluate the use of orlistat 60 mg taken up to 3 times daily as an adjunct to achieve the 10% preoperative weight loss recommended in this bariatric program prior to gastric bypass surgery, showed that Nineteen patients (5 males) and 19 age- and sex-matched controls were included. The mean (SD) initial body mass index for the treatment versus control group was, respectively, 49.5 (10.5) versus 47.2 (4.9) kg/m(2) (p = 0.559). At 3 months, the percent excess weight (EW) loss was 2.4 (3.8) (n = 15) versus 5.5 (7.6) (n = 19) (p = 0.111) and the percent total body weight (TBW) loss was 1.2 (1.9) versus 2.9 (4.1) (p = 0.103). At 6 months, the percent EW loss was 3.6 (6.4) (n = 9) versus 10.2 (8.0) (n = 16) (p = 0.036) and the percent TBW loss was 2.0 (3.4) versus 5.4 (4.2) (p = 0.048)(1).


 101 Practical Weight Loss Tips
How you can lose way the natural way
Un-cover an amazingly simple way of losing weight

(1) "Use of Orlistat 60 mg in the Management of Weight Loss Before Bariatric Surgery (June)" by Malone M, Alger-Mayer SA, Lindstrom J.